Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Second-quarter earnings for Johnson & Johnson soared more than 172%, but its medical device & diagnostics division disappoints.
Medtech companies have collectively paid an estimated $1 billion in compliance with the Affordable Care Act’s 2.3% medical device sales tax.
Edwards Lifesciences wants a federal judge to invalidate a pair of patents covering nerve stimulation sensing technology owned by arch-rival Medtronic.
Abbott agrees to pay $310 million for peripheral stent maker IDEV Technologies and up to $400 million for OptiMedica, which makes laser cataract surgery devices.
U.S. healthcare regulators put their highest-risk Class I label on Medtronic’s Paradigm insulin infusion pump recall.
Minnesota medical device titan Medtronic recalls certain lots of its Consulta and Syncra CRT-P implants after discovering a manufacturing issue that could "compromise device functionality."
Thirty of Intuitive Surgical’s da Vinci surgical robots might not have been properly tested, according to the FDA, which issues a Class II recall on some models and components of the device.